Results 21 to 30 of about 4,642,144 (350)

Therapeutic Plasma Exchange: For Cancer Patients

open access: yesCancer Management and Research, 2022
Yuru Hu, Hanshan Yang, Shaozhi Fu, Jingbo Wu Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, People’s Republic of ChinaCorrespondence: Jingbo Wu; Shaozhi FuDepartment of Oncology, The Affiliated Hospital ...
Hu Y, Yang H, Fu S, Wu J
doaj  

The successful use of therapeutic plasma exchange for severe COVID-19 acute respiratory distress syndrome with multiple organ failure

open access: yesSAGE Open Medical Case Reports, 2020
The COVID-19 pandemic has brought about an urgent need for effective treatment, while conserving vital resources such as intensive care unit beds and ventilators. Antivirals, convalescent plasma, and biologics have been used with mixed results.
Philip Keith   +10 more
semanticscholar   +1 more source

High resolution charge-exchange spectroscopic measurements of aluminum impurity ions in a high temperature plasma [PDF]

open access: yes, 2012
Charge-exchange recombination spectroscopy, which is generally used to measure low-Z impurities in fusion devices, has been used for measuring Al+11 and Al+13 impurities in the Madison Symmetric Torus reversed field pinch.
Chapman, B. E.   +9 more
core   +1 more source

Plasma exchange in critically ill COVID-19 patients

open access: yesCritical Care, 2020
Introduction: The spectrum of coronavirus disease 2019 (COVID-19) ranges from asymptomatic infection to respiratory failure and death of patients Severely affected patients may develop a cytokine storm-like clinical syndrome with multi-organ failure and ...
C. Morath   +5 more
semanticscholar   +1 more source

Perspective: Is therapeutic plasma exchange a viable option for treating Alzheimer's disease?

open access: yesAlzheimer’s & Dementia: Translational Research & Clinical Interventions, 2020
Therapeutic plasma exchange, consisting of removing blood plasma and exchanging it with donated blood products, has been proposed for treating Alzheimer's disease (AD) to remove senescent or toxic factors. In preclinical studies, administration of plasma
Bruno P. Imbimbo   +3 more
doaj   +1 more source

Safety and efficacy of plasma exchange therapy for Kawasaki disease in children in intensive care unit: case series

open access: yesJA Clinical Reports, 2018
Background We have reviewed four cases of Kawasaki disease treated with plasma exchange with 5% albumin in electrolyte-balanced solution, according to the recommended guidelines for Kawasaki disease in the intensive care unit, as their responses to ...
Satoko Noguchi   +4 more
doaj   +1 more source

The effect of plasma exchange in the treatment of anti-neutrophil cytoplasmic antibody-associated small-vessel vasculitis

open access: yesLinchuang shenzangbing zazhi, 2022
Anti-neutrophil cytoplasmic antibody (ANCA) associated small-vessel vasculitis has a high mortality rate. Particularly, patients with renal injury diagnosed by ANCA associated small-vessel vasculitis(AAV) are at high risk of progresses to end-stage renal
Wang Yue-lan   +5 more
doaj  

A Rare case of Guillain-Barré syndrome in pregnancy treated with plasma exchange

open access: yesAsian Journal of Transfusion Science, 2014
Guillain-Barre syndromé (GBS) is an autoimmune disorder. It is rare in pregnancy as there is a decrease in cell-mediated immunity. A case of 28-year-old pregnant woman who presented with acute flaccid quadriplegia suffering from GBS is discussed in this ...
Rahul Vasudev, Tilak Raj Raina
doaj   +1 more source

Plasma Exchange for ANCA-Associated Vasculitis: An International Survey of Patient PreferencesPlain Language Summary

open access: yesKidney Medicine, 2023
Rationale & Objective: We sought to elicit patient preferences regarding the use of plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis (AAV) and its tradeoffs of risk of kidney failure and risk of serious infection.
David Collister   +15 more
doaj  

Intensive Care and Treatment of Severe Guillain–Barré Syndrome

open access: yesFrontiers in Pharmacology, 2021
Guillain–Barré syndrome (GBS) is an acute polyneuropathy mostly characterized by acute flaccid paralysis with or without sensory/autonomous nerve dysfunction. Current immuno therapies including intravenous immunoglobulin (IVIg), plasma exchange (PE), and
Pei Shang   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy